These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28848923)

  • 1. St George's Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium Database.
    Müllerova H; Gelhorn H; Wilson H; Benson VS; Karlsson N; Menjoge S; Rennard SI; Tabberer M; Tal-Singer R; Merrill D; Jones PW
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):141-149. PubMed ID: 28848923
    [No Abstract]   [Full Text] [Related]  

  • 2. The COPD Biomarkers Qualification Consortium Database: Baseline Characteristics of the St George's Respiratory Questionnaire Dataset.
    Tabberer M; Benson VS; Gelhorn H; Wilson H; Karlsson N; Müllerova H; Menjoge S; Rennard SI; Tal-Singer R; Merrill D; Jones PW
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):112-123. PubMed ID: 28848920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline Severity as Predictor of Change in St George's Respiratory Questionnaire Scores in Trials of Long-acting Bronchodilators with COPD Patients.
    Jones PW; Gelhorn H; Karlsson N; Menjoge S; Müllerova H; Rennard SI; Tal-Singer R; Wilson H; Merrill D; Tabberer M
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):132-140. PubMed ID: 28848922
    [No Abstract]   [Full Text] [Related]  

  • 4. Responder Analyses for Treatment Effects in COPD Using the St George's Respiratory Questionnaire.
    Jones PW; Gelhorn H; Wilson H; Karlsson N; Menjoge S; Müllerova H; Rennard SI; Tal-Singer R; Merrill D; Tabberer M
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):124-131. PubMed ID: 28848921
    [No Abstract]   [Full Text] [Related]  

  • 5. The COPD Biomarkers Qualification Consortium St George's Respiratory Questionnaire Manuscripts: Output of a Consortium to Advance Drug Development.
    Tabberer M; Jones PW
    Chronic Obstr Pulm Dis; 2017 Feb; 4(2):109-111. PubMed ID: 28848919
    [No Abstract]   [Full Text] [Related]  

  • 6. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.
    Kim V; Zhao H; Regan E; Han MK; Make BJ; Crapo JD; Jones PW; Curtis JL; Silverman EK; Criner GJ;
    Chest; 2019 Oct; 156(4):685-695. PubMed ID: 31047955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's New with the St George's Respiratory Questionnaire and Why Do We Care?
    Hardin M; Rennard SI
    Chronic Obstr Pulm Dis; 2017 Apr; 4(2):83-86. PubMed ID: 28848916
    [No Abstract]   [Full Text] [Related]  

  • 9. American translation, modification, and validation of the St. George's Respiratory Questionnaire.
    Barr JT; Schumacher GE; Freeman S; LeMoine M; Bakst AW; Jones PW
    Clin Ther; 2000 Sep; 22(9):1121-45. PubMed ID: 11048909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the St. George's Respiratory Questionnaire in Nepal.
    Sherpa CT; LeClerq SL; Singh S; Naithani N; Pangeni R; Karki A; Chokhani RK; Han M; Gyetko M; Tielsch JM; Checkley W
    Chronic Obstr Pulm Dis; 2015 Sep; 2(4):281-289. PubMed ID: 28848850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol.
    Singh D; D'Urzo AD; Chuecos F; Muñoz A; Garcia Gil E
    Respir Res; 2017 May; 18(1):106. PubMed ID: 28558833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
    Calverley PM; Postma DS; Anzueto AR; Make BJ; Eriksson G; Peterson S; Jenkins CR
    Int J Chron Obstruct Pulmon Dis; 2016; 11():381-90. PubMed ID: 26952309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the St George's respiratory questionnaire and risks factors affecting the quality of life of Lebanese COPD and asthma patients.
    Akiki Z; Hallit S; Layoun N; Cherfane M; Sacre H; Waked M; Salameh P
    J Asthma; 2019 Nov; 56(11):1212-1221. PubMed ID: 30359153
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools.
    Alma HJ; de Jong C; Jelusic D; Wittmann M; Schuler M; Kollen BJ; Sanderman R; Schultz K; Kocks JWH; Van der Molen T
    Health Qual Life Outcomes; 2018 Jun; 16(1):130. PubMed ID: 29940980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic Status as a Determinant of Health Status Treatment Response in COPD Trials.
    Jones PW; Gelhorn H; Wilson H; Benson VS; Karlsson N; Menjoge S; Müllerova H; Rennard SI; Tal-Singer R; Merrill D; Tabberer M
    Chronic Obstr Pulm Dis; 2017 Apr; 4(2):150-158. PubMed ID: 28848924
    [No Abstract]   [Full Text] [Related]  

  • 17. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
    Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
    NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature.
    Doll H; Miravitlles M
    Pharmacoeconomics; 2005; 23(4):345-63. PubMed ID: 15853435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.
    Hajiro T; Nishimura K; Tsukino M; Ikeda A; Oga T
    Respir Med; 2000 Sep; 94(9):841-6. PubMed ID: 11001074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA; Cates CJ
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.